Unraveling H7N9’s History

An analysis of stored samples shows that H7N9 precursor H9N2, a virus widespread in chickens, has shown increased fitness in recent years.

Written byKate Yandell
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, GAVIN SCHAEFERThe avian influenza virus H9N2, which helped give rise to the deadly H7N9, evolved to become increasingly infectious in chickens in the years leading up to H7N9’s emergence, according to a paper published yesterday (December 29) in PNAS. H9N2 has been circulating on chicken farms in China since 1994. In recent years, the virus recombined in poultry markets with H7 and N9 viruses that had been passed from wild birds to domestic ducks. The resulting H7N9 flu virus jumped to humans in 2013, and by October 2014 had killed 175 of the 453 people it had infected, according to the World Health Organization. This latest viral analysis sheds light on the genetic changes to H9N2 that may have made H7N9’s emergence possible.

“[The] study reveals the increased H9N2 prevalence in poultry farms in China, due to the emergence of a more infectious and antigenically distinct H9N2 genotype,” Tommy Tsan-Yuk Lam of the University of Hong Kong’s School of Public Health, who was not involved in the study, wrote in an e-mail to The Scientist. “This might partly explain by H7N9 virus chose the H9N2 virus to reassort with.”

“With the combination of vaccine-driven selection and reassortment going on, you got the precursor of the H9N2 that was optimal for complementing H7N9 and going into humans,” said study coauthor Robert Webster of St. Jude Children’s Research Hospital in Memphis, Tennessee.

Webster and his colleagues collaborated with the lab of Jinhua Liu at China Agricultural University in Beijing, which ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies